Mercapturate pathway metabolites of sotorasib, a covalent inhibitor of KRAS


Journal

Toxicology and applied pharmacology
ISSN: 1096-0333
Titre abrégé: Toxicol Appl Pharmacol
Pays: United States
ID NLM: 0416575

Informations de publication

Date de publication:
15 07 2021
Historique:
received: 04 03 2021
revised: 12 05 2021
accepted: 13 05 2021
pubmed: 19 5 2021
medline: 23 6 2021
entrez: 18 5 2021
Statut: ppublish

Résumé

Sotorasib is a first-in class KRAS

Identifiants

pubmed: 34004237
pii: S0041-008X(21)00185-X
doi: 10.1016/j.taap.2021.115578
pii:
doi:

Substances chimiques

Kras protein, rat 0
Piperazines 0
Pyridines 0
Pyrimidines 0
sotorasib 2B2VM6UC8G
Proto-Oncogene Proteins p21(ras) EC 3.6.5.2
Acetylcysteine WYQ7N0BPYC

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115578

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Jonathan A Werner (JA)

Amgen Research, Translational Safety and Bioanalytical Sciences, Thousand Oaks, CA, USA. Electronic address: jowerner@amgen.com.

Rhian Davies (R)

Amgen Research, Translational Safety and Bioanalytical Sciences, Thousand Oaks, CA, USA.

Jan Wahlstrom (J)

Amgen Research, Pharmacokinetics and Drug Metabolism, South San Francisco, CA, USA.

Upendra P Dahal (UP)

Amgen Research, Pharmacokinetics and Drug Metabolism, South San Francisco, CA, USA.

Min Jiang (M)

Amgen Research, Pharmacokinetics and Drug Metabolism, South San Francisco, CA, USA.

Jonathan Stauber (J)

Imabiotech Corp, Billerica, MA, USA.

Benjamin David (B)

Imabiotech Corp, Billerica, MA, USA.

William Siska (W)

Amgen Research, Translational Safety and Bioanalytical Sciences, Thousand Oaks, CA, USA.

Barbara Thomas (B)

Amgen Research Operations, Thousand Oaks, CA, USA.

Katsu Ishida (K)

Amgen Research, Translational Safety and Bioanalytical Sciences, Thousand Oaks, CA, USA.

W Griffith Humphreys (WG)

Aranmore Pharma Consulting, Lawrenceville, NJ, USA.

J Russell Lipford (JR)

Amgen Research, Oncology, Thousand Oaks, CA, USA.

Thomas M Monticello (TM)

Amgen Research, Translational Safety and Bioanalytical Sciences, Thousand Oaks, CA, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH